Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small… EP News Bureau May 11, 2022 The study evaluating Tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
New cancer immunotherapy fails in first Roche trial Reuters Mar 31, 2022 The Skyscraper-II trial was the first to produce results in the final stage of clinical testing in a class of drugs known as…
